MICHAEL CICHOWLAS: Open Payments
NPI 1922014091 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 30 payments from 9 companies in 2025. Trend: 2023 $600 · 2024 $458 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $221 |
| Intra-Sana Laboratories | 3 | $99 |
| PFIZER INC. | 3 | $51 |
| Amgen Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Exact Sciences Corporation | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, RELTONE 200 MG, Rybelsus, Wegovy, NURTEC ODT, OTEZLA, MOUNJARO, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
